Switching associated with initiation of calcitonin gene-related peptide monoclonal antibodies versus non-calcitonin gene-related peptide monoclonal antibodies treatments for prevention of migraine

被引：0
|
作者：
Foster, S. A. [1 ]
Manjelievskaia, J. [2 ]
Ford, J. H. [1 ]
Ye, W. [3 ]
Perry, A. [4 ]
Schuh, K. [1 ]
Wenzel, R. [1 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] IBM Watson Hlth, Armonk, NY USA
[3] Eli Lilly & Co, Indianapolis, IN 46285 USA
[4] IBM Watson Hlth, Roslyn Hts, NY USA
来源：
HEADACHE | 2021年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-87
引用
收藏
页码：75 / 76
页数：2
相关论文
共 50 条
  • [41] Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies in the Treatment of Patients with Concussion
    Rooney, Megan
    Mangold, Sarah
    McVige, Jennifer
    Lis, Dylan
    NEUROLOGY, 2021, 96 (15)
  • [42] Effects of monoclonal antagonist antibodies on calcitonin gene-related peptide receptor function and trafficking
    Manoukian, Raffi
    Sun, Hong
    Miller, Silke
    Shi, Di
    Chan, Brian
    Xu, Cen
    JOURNAL OF HEADACHE AND PAIN, 2019, 20 (1):
  • [43] Calcitonin gene-related peptide (CGRP) in migraine
    Olesen, Jes
    CEPHALALGIA, 2011, 31 (04) : 510 - 510
  • [44] Calcitonin gene-related peptide (CGRP) and migraine
    Durham, PL
    HEADACHE, 2006, 46 : S3 - S8
  • [45] Adherence and Persistence of Calcitonin Gene-Related Peptide Monoclonal Antibodies in Patients with Migraine: A Real-World Study
    Varnado, O.
    Brady, L.
    Zagar, A.
    Robles, Y.
    Hoyt, M.
    Hall, J.
    HEADACHE, 2023, 63 : 184 - 184
  • [46] Persistence, effectiveness, and tolerability of anti-calcitonin gene-related peptide monoclonal antibodies in patients with chronic migraine
    de Dios, Anna
    Pages-Puigdemont, Neus
    Ojeda, Sergio
    Riera, Pau
    Pelegrin, Rebeca
    Morollon, Noemi
    Belvis, Robert
    Real, Jordi
    Masip, Montserrat
    HEADACHE, 2025, 65 (01): : 24 - 34
  • [47] Adherence and Persistence of Calcitonin Gene-Related Peptide Monoclonal Antibodies in Patients with Migraine: A Real-World Study
    Varnado, Oralee
    Brady, Brenna
    Zagar, Anthony J.
    Robles, Yvonne
    Hoyt, Margaret
    Hall, Jerry
    NEUROLOGY, 2023, 100 (17)
  • [48] Persistence, effectiveness, and tolerability of anti-calcitonin gene-related peptide monoclonal antibodies in patients with chronic migraine
    de Dios, Anna
    Pages-Puigdemont, Neus
    Ojeda, Sergio
    Riera, Pau
    Pelegrin, Rebeca
    Morollon, Noemi
    Belvis, Robert
    Real, Jordi
    Masip, Montserrat
    HEADACHE, 2025, 65 (01): : 24 - 34
  • [49] Head-to-head study on efficacy and safety of Monoclonal Antibodies Against Calcitonin Gene-Related Peptide for Migraine
    Russo, C.
    Braca, S.
    Sacca, F.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 684 - 684
  • [50] Calcitonin gene-related peptide (receptor) antibodies: an exciting avenue for migraine treatment
    MaassenVandenBrink, Antoinette
    Terwindt, Gisela M.
    van den Maagdenberg, Arn M. J. M.
    GENOME MEDICINE, 2018, 10
12345